Effect of tirzepatide-induced weight loss on adipose tissue in obesity: rationale and design of the randomized placebo-controlled Tirzepatide Brown and Beige Adipose Tissue Activation (TABFAT) trial
Authors
Andrej Janež (ORCID: https://orcid.org/0000-0002-6594-5254)
Luka Ležaić (ORCID: https://orcid.org/0000-0002-1341-403X)
Andrej Cör (ORCID: https://orcid.org/0000-0001-9562-5465)
Effect of tirzepatide-induced weight loss on adipose tissue in obesity: rationale and design of the randomized placebo-controlled Tirzepatide Brown and Beige Adipose Tissue Activation (TABFAT) trial
Andrej Janež, Luka Ležaić, Andrej Cör, Katja Goričar et al.
Citations
4 citations
Journal
Trials
Topics
Adipose Tissue and Metabolism
Field-Weighted Citation Impact (FWCI)
4.66
article
Effect of tirzepatide-induced weight loss on adipose tissue in obesity: rationale and design of the randomized placebo-controlled Tirzepatide Brown and Beige Adipose Tissue Activation (TABFAT) trial
Andrej Janež, Luka Ležaić, Andrej Cör, Katja Goričar, Simon Horvat, Luka Pušnik, Igor Pušnik, Žiga Snoj, Rok Herman, Mojca Jensterle, Vid Mlacnik, Lara Hanzelic
article en
4 citations
Abstract
No abstract available for this paper.
Publication Tag
TrialsVol. 26(1)
Institutions
University of Primorska (SI), University of Ljubljana (SI), Ljubljana University Medical Centre (SI), Orthopaedic Hospital Valdoltra (SI), Biotechnical Educational Centre Ljubljana (SI)